Gynecologic Oncology

September 16, 2021

The overgrowth of fungi could cause the immune system to stop fighting cancer, according to a study.

September 16, 2021

In an interview with Targeted Oncology, Melissa K. Frey, MD, discussed findings from implementing web-based health information collection of family history in patients with gynecologic cancers.

September 15, 2021

Results of a phase 2 study demonstrate that the anti-programmed death-1 (PD-1) antibody balstilimab from Agenus Inc. provides meaningful and durable clinical activity in patients with previously treated, recurrent/metastatic cervical cancer.

September 14, 2021

The official declaration means more funding for research initiatives.

August 16, 2021

The FDA has accepted a new supplemental biologics license application for pembrolizumab, an anti-PD-1 therapy, as a single agent for the treatment of patients with advanced endometrial carcinoma that is microsatellite instability-high or mismatch repair deficient, who have diseased progression following prior systemic therapy in any setting and are not candidates for curative surgery or radiation.

August 11, 2021

Pregnant women who had cancer previously or currently have cancer were more likely to experience comorbidities and in-hospital complications, depending on cancer type.

August 11, 2021

The results, according to the study authors, demonstrate that screening the general population for tubal and ovarian cancer each year does not result in a survival benefit.

August 06, 2021

The American College of Obstetricians and Gynecologists (ACOG) recently published an updated committee opinion regarding morcellation of presumed uterine leiomyoma. Here are the key points.

July 14, 2021

We hear from Christine Isaacs, MD about the new ASCCP guidelines and what they mean for ob/gyns.

July 14, 2021

The unmet need for personalized follow-up care due to a wide variety of health burdens after treatment needs to be addressed.